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Abstract
Primary cardiac tumors are rare, particularly in the elderly population. The patient described in this report
presented with symptoms of dyspnea on exertion, leg swelling, and weight gain and was found to have two
histologically distinct cardiac masses: atrial myxoma with concurrent aortic fibroelastoma. Given her history
of cirrhosis and end-stage renal disease, the patient was a poor surgical candidate but opted for excision of
both masses. The patient eventually succumbed to her cirrhosis six weeks after presentation. In this report,
we advocate for further research into medical management for the unique presentation of concurrent
primary cardiac tumors in high-operative-risk patients, particularly those whose symptoms are mostly due
to tamponade.
Categories: Cardiology, Emergency Medicine
Keywords: primary cardiac tumors, atrial myxoma, tamponade, emergency echocardiography, imminent mitral
annular obstruction
Introduction
This was presented in the Medical Student/Resident Cardiothoracic Surgery Poster session at the virtual
Chest Annual Meeting October 18-21, 2020. Atrial myxomas are the most common primary cardiac tumor,
constituting half of all primary cardiac tumors and occurring predominantly in adults [1-3]. While the
prevalence of primary cardiac tumors is approximately 3% overall, of those, 75% are benign and include
other types such as lipomas, papillary fibroelastomas, and rhabdomyomas [3]. Cardiac tumors can be tricky
to identify on initial presentation because symptoms will vary based on the tumor’s potential embolization,
location, and size. Atrial myxomas tend to occur in middle age to late adulthood, much less so in the
geriatric population [4]. While there have been reports documenting unique presentations of primary
cardiac tumors, there is a paucity of literature surrounding conservative management in elderly, high-
operative-risk patients with two concurrent primary cardiac tumors. We report a case of an elderly patient
with two distinct histologically cardiac masses, initially presenting with symptoms of heart failure.
Case Presentation
A 70-year-old female with a past medical history of squamous cell carcinoma, type II diabetes, rheumatoid
arthritis, alcoholic cirrhosis with esophageal varices, tobacco abuse, and stage five chronic kidney
disease presented to the emergency department with generalized abdominal pain, leg swelling, four weeks of
dyspnea on exertion, and a weight gain of 29 pounds. She had been taking intermittent furosemide dosing at
home with decreased response compared to baseline. Family history was notable for multiple types of cancer
(ovarian, lung, breast), although the patient was up-to-date and negative for all relevant cancer screenings.
She was hypertensive (154/58 mmHg), tachycardic (104 beats per minute), febrile (100.3 degrees
Fahrenheit), and borderline tachypneic (20 breaths per minute) at presentation. Physical exam was notable
for bilateral lower extremity 3+ pitting edema, an abdominal fluid wave, a systolic murmur at the left lower
sternal border, and bibasilar crackles. Labs were significant for normocytic anemia, elevated blood urea
nitrogen (BUN) and creatinine, hyponatremia, hypercalcemia, hypoalbuminemia, and elevated alkaline
phosphatase. Troponins were negative, but the patient had elevated pro-B-type natriuretic peptide
(proBNP). The chest radiograph demonstrated cardiomegaly (Figure 1).
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FIGURE 1: Chest x-ray (anterior-posterior view)
A large pericardial effusion, abdominal ascites, and a left atrial mass that was echogenic were found with a
point of care ultrasound. There were concerning signs for tamponade indicated by collapse of the right atria
during diastole on the official 2D echocardiogram (Figure 2, 3).
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FIGURE 2: Transthoracic echocardiogram (TTE) left atrial myxoma 4-
chamber view
4CHA - 4 chamber, LV - left ventricular, RV - right ventricular, RA - right atrium
FIGURE 3: Transthoracic echocardiogram (TTE) left atrial myxoma
parasternal long-axis view
PLAX - parasternal long-axis view, RV - right ventricle, LV - left ventricle
A total of 760cc of transudative fluid was drained via pericardial tap, resulting in the resolution of the
patient’s symptoms. Two masses were evident on the transesophageal echocardiogram (TEE, Figure 4). The
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first was affixed to the septum between the atria, was well-circumscribed, and had some echolucency and
measuring 3.8 by 4.5cm. The second mass was echogenic, measuring 4 by 5mm, and was located near the
aortic side of the coronary cusp (left).
FIGURE 4: Transesophageal echocardiogram (TEE), left atrial myxoma
SVC - superior vena cava
Conservative management was discussed, given her comorbid conditions. However, the patient chose to
pursue surgery and, 10 days after presentation, cardiothoracic surgery excised the two masses. They reported
a near annular mitral obstruction from a "ball valve" consequence of the mass. The pathology report of the
specimens taken during surgery determined the masses to be respectively an atrial myxoma and an aortic
fibroelastoma. The pathologist also commented that the pericardial biopsy showed evidence of sclerosing
pericarditis that appeared chronic. Unfortunately, due to decompensated cirrhosis, the patient passed away
after a prolonged hospital course and inpatient rehabilitation stay, approximately six weeks after
presentation.
Discussion
Cardiac tumors were once only something that could be studied during an autopsy, but in the last 64 years,
the invention of 2-dimensional echocardiography, magnetic resonance imaging, and computed tomography
have allowed physicians to diagnose such neoplasms prior to the death of a patient [5]. These cardiac tumors
can be primary (benign or malignant) or secondary (always malignant) [5]. The occurrence of secondary
cardiac tumors has been reported 100 times more common than primary tumors [5-7]. Assessment and
treatment of cardiac tumors before significant symptoms leads to a better prognosis; however, the challenge
for cardiologists, surgeons, and emergency physicians is the rarity of primary cardiac tumors, as well as a
lack of knowledge of how to treat them for patients who are surgically high-risk [6,7].
The treatment of primary cardiac tumors is surgical [7]. The generally accepted treatment of these rare
myxomas is operative resection [5]. Gupta et al. (2020) note that sufficient data to inform the creation of
guidelines for cardiac tumors do not exist; thus, there is no guideline‐directed management of primary
cardiac tumors for even a patient who is not as high-risk as our patient [7]. There are no known medicines
that would shrink them or prevent them from growing further [5].
Our literature review resulted in only five documented cases of primary cardiac tumors that were both
primary and different histologically; such cases are very uncommon [8-11]. Due to the untoward sequelae of
mitral valve stenosis and embolization from the tumor, atrial myxomas and aortic fibroelastomas are
generally treated with surgical resection [7]. However, for elderly populations with comorbid conditions,
these interventions become far riskier. By undergoing surgical treatment, this patient risked exacerbating
her kidney disease; as she was already at stage V, this would mean liver failure. Furthermore, it is likely that
her acutely severe presentation was related to tamponade instead of stenosis of the mitral valve since
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pericardiocentesis relieved the patient’s symptoms. This indication potentially validates the option of
medical management. Some studies have reported managing atrial myxoma conservatively for high-risk
surgical patients [12, 13], yet no report exists on patients with concurrent cardiac tumors. Serial
echocardiography to monitor and anticoagulation to prevent embolization could be suitable options for
higher-risk patients, but because of the low disease prevalence, research on the long-term outcomes of this
approach is limited [14, 15]. We advocate for a conservative approach in high-risk patients with concurrent
primary cardiac tumors whose presenting symptoms are relieved by pericardiocentesis. Ultimately, further
research on these types of patients is indicated.
Conclusions
In this report, we detail a unique case presentation of atrial myxoma with concurrent fibroelastoma in an
elderly female. There have been no prior studies detailing outcomes of non-surgical management in high-
risk patients with concurrent cardiac tumors. In such patients presenting with correlative imaging findings
whose symptoms are the result of tamponade rather than mitral valve obstruction, medical management
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